Infusion Pumps: Technology and Market 2013-2023
Your guide to trends and revenue prospects for infusion pumps
What does the future hold for the infusion pumps market? Visiongain's new report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for infusion pumps. There's rising demand for those products.
Our study lets you assess sales data at overall world market, submarket and national level. There you find that industry's most promising and lucrative segments, helping your research and analyses.
Forecasts and other analyses to help you stay ahead in knowledge
In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT and Porter's five force analysis), business news, outlooks and developmental trends. Also, you receive 55 tables and 51 charts.
You discover industry dynamics and growth potentials - the following sections show what you find in our new report.
Discover prospects for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2023 for these submarkets:
With our investigation you gain business research and analysis with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints. See what's likely to achieve the most success.
You can gain competitive advantages by understanding the trends, opportunities and challenges facing the infusion pumps market.
Our work also breaks the main world forecast into leading geographical markets.
What prospects for leading regions and countries?
Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There exist many opportunities for medical device companies developing infusion pump technologies. See prospects for the industry.
You get individual forecasts to 2023 for nine national markets, finding overall revenues:
What influences the infusion pumps market?
Our report discusses issues and events affecting that industry and market from 2013, looking ahead:
Leading companies and 2017 market value
What will happen next? We predict the overall world market for infusion pumps will reach $9.8bn in 2017, and expand further to 2023.
Our study shows you what technologies, products and organisations hold greatest potential.
From 2013 to 2023, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.
Seven ways Infusion Pumps: Technology and Market 2013-2023 helps you
To sum up, our investigation gives you the following knowledge:
That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.
With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.
Discover technological and commercial prospects from 2013 by ordering now
Visiongain's study is for everyone needing analysis of the industry and market for infusion pumps. You find data, trends and predictions. Please ask for our report now.
What does the future hold for the infusion pumps market? Visiongain's new report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for infusion pumps. There's rising demand for those products.
Our study lets you assess sales data at overall world market, submarket and national level. There you find that industry's most promising and lucrative segments, helping your research and analyses.
Forecasts and other analyses to help you stay ahead in knowledge
In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT and Porter's five force analysis), business news, outlooks and developmental trends. Also, you receive 55 tables and 51 charts.
You discover industry dynamics and growth potentials - the following sections show what you find in our new report.
Discover prospects for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2023 for these submarkets:
- Insulin pumps
- Enteral feeding pumps
- Other infusion pumps (including PCA and chemotherapy pumps).
With our investigation you gain business research and analysis with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints. See what's likely to achieve the most success.
You can gain competitive advantages by understanding the trends, opportunities and challenges facing the infusion pumps market.
Our work also breaks the main world forecast into leading geographical markets.
What prospects for leading regions and countries?
Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There exist many opportunities for medical device companies developing infusion pump technologies. See prospects for the industry.
You get individual forecasts to 2023 for nine national markets, finding overall revenues:
- US
- Japan
- Germany, France, UK, Italy and Spain
- India and China.
What influences the infusion pumps market?
Our report discusses issues and events affecting that industry and market from 2013, looking ahead:
- Shifting dynamics in the infusion pumps market
- Escalating levels of worldwide obesity and diabetes
- Reimbursement outlook in key segments of the market
- Strengths and weaknesses of the infusion pumps market
- The microenvironment in which companies operate
- Medical device excise tax
- Competition from pharmaceuticals and other drug delivery technologies
- Regulatory harmonisation across major international markets
- Expanding healthcare coverage in emerging markets
Leading companies and 2017 market value
What will happen next? We predict the overall world market for infusion pumps will reach $9.8bn in 2017, and expand further to 2023.
Our study shows you what technologies, products and organisations hold greatest potential.
From 2013 to 2023, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.
Seven ways Infusion Pumps: Technology and Market 2013-2023 helps you
To sum up, our investigation gives you the following knowledge:
- Revenues to 2023 for the overall world market and submarkets - you will discover where commercial growth will occur
- Forecasting to 2023 for US, Japan, Germany, France, UK, Spain, Italy, India and China - you see leading national sales potentials
- Assessment of competing drug delivery technologies - you find activities, products, capabilities and outlooks
- Understanding of competition and opportunities - you see what affects that industry, learning what shapes its future
- Analysis of what stimulates and restrains the industry and market - you assess challenges and strengths
- Analysis of microenvironment - helping you compete and gain advantages
- Prospects for established firms and those seeking to enter the sector - you explore needs, practices and outlooks for success.
That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.
With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.
Discover technological and commercial prospects from 2013 by ordering now
Visiongain's study is for everyone needing analysis of the industry and market for infusion pumps. You find data, trends and predictions. Please ask for our report now.
1. EXECUTIVE SUMMARY
1.1 Infusion Pumps Market Highlights
1.2 Overview of Chapter Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Infusion Pumps
2. INTRODUCTION
2.1 What is an Infusion Pump?
2.2 Types of Infusion
2.3 Types of Pumps
2.3.1 Gravity Controlled Pumps
2.3.2 Positive Displacement Pumps
2.3.2.1 Drip Rate Pumps
2.3.2.2 Volumetric Pumps
2.3.2.3 Syringe Pumps
2.3.2.4 Multi-Channel Pumps
2.4 History of Infusion Pumps
2.5 What Clinical Settings Will Infusion Pumps be Useful?
2.5.1 Infusion Pumps for Diabetes
2.5.2 Infusion Pumps for Chemotherapy
2.5.3 Infusion Pumps for Analgesia
2.5.4 Infusion Pumps for Enteral Feeding
2.5.5 Other Uses for Infusion Pumps
2.6 Advantages and Disadvantages of Infusion Pumps
2.7 Regulation of the Infusion Pump Market
2.7.1 The US Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1 Post Marketing Surveillance in the EU
2.8 Infusion Pump Market
2.8.1 Infusion Pump Market Definition
3. THE GLOBAL INFUSION PUMPS MARKET, 2011-2023
3.1 The Global Medical Devices Market, 2011
3.2 The Global Infusion Pumps Market, 2011
3.2.1 The Infusion Pumps Market: Segment Breakdown, 2011
3.2.2 Then Infusion Pumps Market: Regional Market Breakdown, 2011
3.2.2.1 The US Market, 2011
3.2.2.2 The European Market, 2011
3.2.2.3 The Japanese Market, 2011
3.2.2.4 The Chinese Market, 2011
3.2.2.5 The Indian Market, 2011
3.3 The Infusion Pumps Market Forecast, 2012-2023
3.3.1 The Infusion Pumps Market Forecast, 2012-2017
3.3.2 The Infusion Pumps Market Forecast, 2017-2023
3.4 The Infusion Pumps Market Forecast by Region, 2012-2023
3.4.1 The US Infusion Pumps Market Forecast, 2012-2023
3.4.1.1 Potential Effects of the US Medical Device Excise Tax
3.4.2 The European Infusion Pumps Market Forecast, 2012-2023
3.4.2.1 The German Infusion Pumps Market Forecast, 2012-2023
3.4.2.2 The French Infusion Pumps Market Forecast, 2012-2023
3.4.2.3 The UK Infusion Pumps Market Forecast, 2012-2023
3.4.2.4 The Spanish Infusion Pumps Market Forecast, 2012-2023
3.4.2.5 The Italian Infusion Pumps Market Forecast, 2012-2023
3.4.3 The Japanese Infusion Pumps Market Forecast, 2012-2023
3.4.4 The Chinese Infusion Pumps Market Forecast, 2012-2023
3.4.5 The Indian Infusion Pumps Market Forecast, 2012-2023
3.5 Changing Market Shares of the Leading Regional Markets, 2011-2023
4. INSULIN PUMPS
4.1 Introduction to Insulin Pumps
4.1.1 The Dosing of Insulin in Insulin Pumps
4.1.1.1 Bolus Infusion
4.1.1.2 Basal Infusion
4.1.2 The Advantages and Disadvantages of Insulin Pumps
4.1.3 Human Insulins and Analogues Primarily Used in Insulin Pumps
4.2 Current State of the Insulin Infusion Pumps Market
4.2.1 Leading Products in the Insulin Pump Market, 2013
4.2.1.1 OmniPod (Insulet Corporation)
4.2.1.2 Minimed Paradigm Revel (Medtronic)
4.2.1.3 OneTouch Ping (Animas Corporation)
4.2.1.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
4.2.1.5 Deltec Cozmo Insulin Pump (Smith Medical)
4.2.1.6 SpringZone (D. Medical Industries)
4.2.1.7 t:SlimInsulin Pump (Tandem Diabetes Care)
4.2.1.8 Other Notable Products
4.3 The Insulin Pump Market Forecast
4.3.1 The Insulin Pump Market Forecast, 2012-2017
4.3.2 The Insulin Pump Market Forecast, 2017-2023
4.3.3 Drivers and Restraints in the Insulin Pump Market, 2012-2023
4.4 The Insulin Pump Development Pipeline, 2013
4.4.1 Finesse Personal Insulin Patch (J&J)
4.4.2 SOLO Micropump (Roche)
4.4.3 Jewel Pump (Debiotech)
4.4.4 Artificial Pancreas (Juvenile Diabetes Research Foundation)
4.4.5 DANA Diabecare IISG (SOOIL)
4.4.6 Next Generation OmniPod (Insulet Corporation)
4.4.7 Asante Snap (Asante Solutions)
4.4.8 CeQur (CeQur)
4.5 Concluding Remarks
4.5.1 Security Risks with Insulin Pumps
5. ENTERAL FEEDING PUMPS
5.1 Introduction to Enteral Feeding Pumps
5.1.1 Clinical Settings That May Require Enteral Feeding
5.1.2 Advantages and Disadvantages of Enteral Feeding
5.1.3 Delivery of Enteral Feeding
5.1.3.1 Tube Placements Used in Enteral Feeding
5.1.4 Enteral Feeding at Home
5.1.4.1 Increasing Numbers of Patients Now Opt for Home Enteral Feeding
5.2 The Current State of the Enteral Feeding Pump Market
5.3 Products in the Enteral Feeding Pump Market, 2013
5.3.1 Compat DualFlo Enteral Feeding Pump (Nestle Healthcare)
5.3.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
5.3.3 EnteraLite Infinity (Moog)
5.3.4 APPLIX Vision (Fresenius Kabi)
5.3.5 MiniFlo (Fresenius Kabi)
5.3.6 Nutricia FloCare Infinity Pump (Nutricia)
5.3.7 Sapphire TPN (Q Core Medical)
5.3.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
5.4 The Global Enteral Feeding Pumps Market Forecast, 2012-2017
5.4.1 Abbott to Exit the US Enteral Feeding Market in 2013
5.4.2 An Aging Population and Rising Cases of Premature Births Will Drive Growth in the
Enteral Feeding Pumps Market
5.5 The Global Enteral Feeding Pumps Market Forecast, 2017-2023
5.5.1 Increasing Demand for Homecare Solutions and Portability
5.6 Drivers and Restraints in the Global Enteral Feeding Pump Market
6. OTHER INFUSION PUMPS IN THE MARKET
6.1 Other Infusion Pumps Market Definition
6.1.1 The Other Infusion Pumps Market, 2011
6.1.2 The Other Infusion Pumps Market Forecast, 2012-2023
6.2 Chemotherapy Pumps
6.2.1 What is Chemotherapy?
6.2.1.1 Chemotherapy Dosing
6.2.2 Introduction to Chemotherapy Pumps
6.2.3 Advantages and Disadvantages of Chemotherapy Pumps
6.2.4 Leading Drugs in the Cancer Therapeutics Market, 2011
6.2.5 The Chemotherapy Pump Market
6.2.5.1 The Leading Products in the Chemotherapy Pump Market, 2012
6.2.5.1.1 Infusor Infusion Pump (Baxter)
6.2.5.1.2 CODMAN 3000 (DePuy, a subsidiary of Johnson & Johnson)
6.2.5.1.3 Perfusor Space (B.Braun)
6.2.5.1.4 Optima MS (Fresenius Kabi)
6.2.5.1.5 CADD Legacy-1 (Smith Medical)
6.2.5.1.6 Other Infusion Pumps for Chemotherapy
6.2.6 Drivers and Restraints for the Global Chemotherapy Pump Market
6.2.7 The Chemotherapy Pump Pipeline
6.2.7.1 Metronomic Biofeedback Pump (Pharmaco-Kinesis Corporation)
6.2.8 Concluding Remarks
6.3 Patient Controlled Analgesia
6.3.1 Introduction to Patient Controlled Analgesia
6.3.1.1 What are PCA Pumps?
6.3.1.2 How Does a PCA Pump Work?
6.3.1.3 Clinical Settings Where PCA Pumps are Used
6.3.1.4 Advantages and Disadvantages of PCA Pumps
6.3.2 Leading Drugs in the Pain Relief Market
6.3.2.1 Narcotic Drugs
6.3.2.2 The Narcotics Drug Market, 2012-2022
6.3.3 The PCA Pump Market
6.3.3.1 Leading Products in the PCA Pump Market
6.3.3.1.1 LifeCare PCA with Hospira MedNet Software (Hospira)
6.3.3.1.2 GemStar Pain Management System (Hospira)
6.3.3.1.3 Alaris PCA (CareFusion)
6.3.3.1.4 PCA II (Baxter)
6.3.3.1.5 Curlin PainSmart IOD Pain Management System (B Braun)
6.3.3.1.6 CADD-Solaris Ambulatory Infusion Pump (Smith Medical)
6.3.4 PCA Infusion Pump Under Development, 2013
6.3.4.1 MIP (Debiotech)
6.3.5 Drivers and Restraints in the Global PCA Pump Market
6.3.6 Concluding Remarks
7. COMPETING TECHNOLOGY
7.1 Drug Delivery Technologies
7.1.1 Introduction to Drug Delivery Technologies (DDT)
7.1.2 Types of Technologies for Drug Delivery
7.1.2.1 Sustained/Controlled Release Systems
7.1.2.2 Injection
7.1.2.3 Needle Free Injections
7.1.2.4 Pulmonary, Buccal and Nasal Delivery
7.1.2.5 Pills and Capsules
7.2 The Global Drug Delivery Market, 2011
7.2.1 Drug Delivery Technology Market by Region, 2011
7.3 Drug Delivery Technology Market Forecast, 2012-2022
7.4 Key Developments and Pipeline Products
7.5 Concluding Remarks
8. QUALITATIVE ANALYSIS OF THE INFUSION PUMPS MARKET, 2013-2023
8.1 SWOT Analysis
8.2 Strengths
8.2.1 Pumpers Have Improved Quality of Life and Less Frequent Hospital Visits
8.2.2 Infusion Pumps Provide Highly Accurate Dosing at Regular Intervals
8.2.3 Infusion Pumps Can be Used in a Wide Range of Clinical Indications
8.2.4 Patient Demographics
8.3 Weaknesses
8.3.1 Expensive Technologies May Restrain the Market
8.3.2 Regulatory Authorities are Reluctant to Take Risks
8.3.3 Pumps Are Cumbersome to Use and May Put Off Potential Patients
8.4 Opportunities
8.4.1 Off-Patent Drugs Will Help to Drive the Market
8.4.2 Emerging Economies Will Help to Drive the Market
8.4.2.1 China's 12th Five Year Plan (2010-2015)
8.4.3 Technological Developments Will Help Drive the Market
8.5 Threats
8.5.1 Novel Drug Delivery Systems May be Cheaper and More Effective
8.5.2 Safety Concerns Regarding Infusion Pumps Will Act to Restrain the Market
8.5.3 Cost Effectiveness May be Difficult to Prove
8.5.4 Poor Macroeconomic Conditions in Key Regions of the Market
8.5.5 Increasing Bargaining Power of Buyers
8.6 Porter's Five Force Analysis
8.6.1 Rivalry Among Competitors [High]
8.6.2 Threat of New Entrants [Medium]
8.6.3 Power of Suppliers [Low]
8.6.4 Bargaining Power of Buyers [High]
8.6.5 Threat of Substitues [Medium]
9. CONCLUSIONS
9.1 The Global Infusion Pump Market Will See Consistent Growth Over The Period 2012-2023
9.2 The Insulin Pump Market Will Continue to be the Largest Market Segment
9.3 Safety Concerns Will Continue to Restrain the Market
1.1 Infusion Pumps Market Highlights
1.2 Overview of Chapter Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Infusion Pumps
2. INTRODUCTION
2.1 What is an Infusion Pump?
2.2 Types of Infusion
2.3 Types of Pumps
2.3.1 Gravity Controlled Pumps
2.3.2 Positive Displacement Pumps
2.3.2.1 Drip Rate Pumps
2.3.2.2 Volumetric Pumps
2.3.2.3 Syringe Pumps
2.3.2.4 Multi-Channel Pumps
2.4 History of Infusion Pumps
2.5 What Clinical Settings Will Infusion Pumps be Useful?
2.5.1 Infusion Pumps for Diabetes
2.5.2 Infusion Pumps for Chemotherapy
2.5.3 Infusion Pumps for Analgesia
2.5.4 Infusion Pumps for Enteral Feeding
2.5.5 Other Uses for Infusion Pumps
2.6 Advantages and Disadvantages of Infusion Pumps
2.7 Regulation of the Infusion Pump Market
2.7.1 The US Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1 Post Marketing Surveillance in the EU
2.8 Infusion Pump Market
2.8.1 Infusion Pump Market Definition
3. THE GLOBAL INFUSION PUMPS MARKET, 2011-2023
3.1 The Global Medical Devices Market, 2011
3.2 The Global Infusion Pumps Market, 2011
3.2.1 The Infusion Pumps Market: Segment Breakdown, 2011
3.2.2 Then Infusion Pumps Market: Regional Market Breakdown, 2011
3.2.2.1 The US Market, 2011
3.2.2.2 The European Market, 2011
3.2.2.3 The Japanese Market, 2011
3.2.2.4 The Chinese Market, 2011
3.2.2.5 The Indian Market, 2011
3.3 The Infusion Pumps Market Forecast, 2012-2023
3.3.1 The Infusion Pumps Market Forecast, 2012-2017
3.3.2 The Infusion Pumps Market Forecast, 2017-2023
3.4 The Infusion Pumps Market Forecast by Region, 2012-2023
3.4.1 The US Infusion Pumps Market Forecast, 2012-2023
3.4.1.1 Potential Effects of the US Medical Device Excise Tax
3.4.2 The European Infusion Pumps Market Forecast, 2012-2023
3.4.2.1 The German Infusion Pumps Market Forecast, 2012-2023
3.4.2.2 The French Infusion Pumps Market Forecast, 2012-2023
3.4.2.3 The UK Infusion Pumps Market Forecast, 2012-2023
3.4.2.4 The Spanish Infusion Pumps Market Forecast, 2012-2023
3.4.2.5 The Italian Infusion Pumps Market Forecast, 2012-2023
3.4.3 The Japanese Infusion Pumps Market Forecast, 2012-2023
3.4.4 The Chinese Infusion Pumps Market Forecast, 2012-2023
3.4.5 The Indian Infusion Pumps Market Forecast, 2012-2023
3.5 Changing Market Shares of the Leading Regional Markets, 2011-2023
4. INSULIN PUMPS
4.1 Introduction to Insulin Pumps
4.1.1 The Dosing of Insulin in Insulin Pumps
4.1.1.1 Bolus Infusion
4.1.1.2 Basal Infusion
4.1.2 The Advantages and Disadvantages of Insulin Pumps
4.1.3 Human Insulins and Analogues Primarily Used in Insulin Pumps
4.2 Current State of the Insulin Infusion Pumps Market
4.2.1 Leading Products in the Insulin Pump Market, 2013
4.2.1.1 OmniPod (Insulet Corporation)
4.2.1.2 Minimed Paradigm Revel (Medtronic)
4.2.1.3 OneTouch Ping (Animas Corporation)
4.2.1.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
4.2.1.5 Deltec Cozmo Insulin Pump (Smith Medical)
4.2.1.6 SpringZone (D. Medical Industries)
4.2.1.7 t:SlimInsulin Pump (Tandem Diabetes Care)
4.2.1.8 Other Notable Products
4.3 The Insulin Pump Market Forecast
4.3.1 The Insulin Pump Market Forecast, 2012-2017
4.3.2 The Insulin Pump Market Forecast, 2017-2023
4.3.3 Drivers and Restraints in the Insulin Pump Market, 2012-2023
4.4 The Insulin Pump Development Pipeline, 2013
4.4.1 Finesse Personal Insulin Patch (J&J)
4.4.2 SOLO Micropump (Roche)
4.4.3 Jewel Pump (Debiotech)
4.4.4 Artificial Pancreas (Juvenile Diabetes Research Foundation)
4.4.5 DANA Diabecare IISG (SOOIL)
4.4.6 Next Generation OmniPod (Insulet Corporation)
4.4.7 Asante Snap (Asante Solutions)
4.4.8 CeQur (CeQur)
4.5 Concluding Remarks
4.5.1 Security Risks with Insulin Pumps
5. ENTERAL FEEDING PUMPS
5.1 Introduction to Enteral Feeding Pumps
5.1.1 Clinical Settings That May Require Enteral Feeding
5.1.2 Advantages and Disadvantages of Enteral Feeding
5.1.3 Delivery of Enteral Feeding
5.1.3.1 Tube Placements Used in Enteral Feeding
5.1.4 Enteral Feeding at Home
5.1.4.1 Increasing Numbers of Patients Now Opt for Home Enteral Feeding
5.2 The Current State of the Enteral Feeding Pump Market
5.3 Products in the Enteral Feeding Pump Market, 2013
5.3.1 Compat DualFlo Enteral Feeding Pump (Nestle Healthcare)
5.3.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
5.3.3 EnteraLite Infinity (Moog)
5.3.4 APPLIX Vision (Fresenius Kabi)
5.3.5 MiniFlo (Fresenius Kabi)
5.3.6 Nutricia FloCare Infinity Pump (Nutricia)
5.3.7 Sapphire TPN (Q Core Medical)
5.3.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
5.4 The Global Enteral Feeding Pumps Market Forecast, 2012-2017
5.4.1 Abbott to Exit the US Enteral Feeding Market in 2013
5.4.2 An Aging Population and Rising Cases of Premature Births Will Drive Growth in the
Enteral Feeding Pumps Market
5.5 The Global Enteral Feeding Pumps Market Forecast, 2017-2023
5.5.1 Increasing Demand for Homecare Solutions and Portability
5.6 Drivers and Restraints in the Global Enteral Feeding Pump Market
6. OTHER INFUSION PUMPS IN THE MARKET
6.1 Other Infusion Pumps Market Definition
6.1.1 The Other Infusion Pumps Market, 2011
6.1.2 The Other Infusion Pumps Market Forecast, 2012-2023
6.2 Chemotherapy Pumps
6.2.1 What is Chemotherapy?
6.2.1.1 Chemotherapy Dosing
6.2.2 Introduction to Chemotherapy Pumps
6.2.3 Advantages and Disadvantages of Chemotherapy Pumps
6.2.4 Leading Drugs in the Cancer Therapeutics Market, 2011
6.2.5 The Chemotherapy Pump Market
6.2.5.1 The Leading Products in the Chemotherapy Pump Market, 2012
6.2.5.1.1 Infusor Infusion Pump (Baxter)
6.2.5.1.2 CODMAN 3000 (DePuy, a subsidiary of Johnson & Johnson)
6.2.5.1.3 Perfusor Space (B.Braun)
6.2.5.1.4 Optima MS (Fresenius Kabi)
6.2.5.1.5 CADD Legacy-1 (Smith Medical)
6.2.5.1.6 Other Infusion Pumps for Chemotherapy
6.2.6 Drivers and Restraints for the Global Chemotherapy Pump Market
6.2.7 The Chemotherapy Pump Pipeline
6.2.7.1 Metronomic Biofeedback Pump (Pharmaco-Kinesis Corporation)
6.2.8 Concluding Remarks
6.3 Patient Controlled Analgesia
6.3.1 Introduction to Patient Controlled Analgesia
6.3.1.1 What are PCA Pumps?
6.3.1.2 How Does a PCA Pump Work?
6.3.1.3 Clinical Settings Where PCA Pumps are Used
6.3.1.4 Advantages and Disadvantages of PCA Pumps
6.3.2 Leading Drugs in the Pain Relief Market
6.3.2.1 Narcotic Drugs
6.3.2.2 The Narcotics Drug Market, 2012-2022
6.3.3 The PCA Pump Market
6.3.3.1 Leading Products in the PCA Pump Market
6.3.3.1.1 LifeCare PCA with Hospira MedNet Software (Hospira)
6.3.3.1.2 GemStar Pain Management System (Hospira)
6.3.3.1.3 Alaris PCA (CareFusion)
6.3.3.1.4 PCA II (Baxter)
6.3.3.1.5 Curlin PainSmart IOD Pain Management System (B Braun)
6.3.3.1.6 CADD-Solaris Ambulatory Infusion Pump (Smith Medical)
6.3.4 PCA Infusion Pump Under Development, 2013
6.3.4.1 MIP (Debiotech)
6.3.5 Drivers and Restraints in the Global PCA Pump Market
6.3.6 Concluding Remarks
7. COMPETING TECHNOLOGY
7.1 Drug Delivery Technologies
7.1.1 Introduction to Drug Delivery Technologies (DDT)
7.1.2 Types of Technologies for Drug Delivery
7.1.2.1 Sustained/Controlled Release Systems
7.1.2.2 Injection
7.1.2.3 Needle Free Injections
7.1.2.4 Pulmonary, Buccal and Nasal Delivery
7.1.2.5 Pills and Capsules
7.2 The Global Drug Delivery Market, 2011
7.2.1 Drug Delivery Technology Market by Region, 2011
7.3 Drug Delivery Technology Market Forecast, 2012-2022
7.4 Key Developments and Pipeline Products
7.5 Concluding Remarks
8. QUALITATIVE ANALYSIS OF THE INFUSION PUMPS MARKET, 2013-2023
8.1 SWOT Analysis
8.2 Strengths
8.2.1 Pumpers Have Improved Quality of Life and Less Frequent Hospital Visits
8.2.2 Infusion Pumps Provide Highly Accurate Dosing at Regular Intervals
8.2.3 Infusion Pumps Can be Used in a Wide Range of Clinical Indications
8.2.4 Patient Demographics
8.3 Weaknesses
8.3.1 Expensive Technologies May Restrain the Market
8.3.2 Regulatory Authorities are Reluctant to Take Risks
8.3.3 Pumps Are Cumbersome to Use and May Put Off Potential Patients
8.4 Opportunities
8.4.1 Off-Patent Drugs Will Help to Drive the Market
8.4.2 Emerging Economies Will Help to Drive the Market
8.4.2.1 China's 12th Five Year Plan (2010-2015)
8.4.3 Technological Developments Will Help Drive the Market
8.5 Threats
8.5.1 Novel Drug Delivery Systems May be Cheaper and More Effective
8.5.2 Safety Concerns Regarding Infusion Pumps Will Act to Restrain the Market
8.5.3 Cost Effectiveness May be Difficult to Prove
8.5.4 Poor Macroeconomic Conditions in Key Regions of the Market
8.5.5 Increasing Bargaining Power of Buyers
8.6 Porter's Five Force Analysis
8.6.1 Rivalry Among Competitors [High]
8.6.2 Threat of New Entrants [Medium]
8.6.3 Power of Suppliers [Low]
8.6.4 Bargaining Power of Buyers [High]
8.6.5 Threat of Substitues [Medium]
9. CONCLUSIONS
9.1 The Global Infusion Pump Market Will See Consistent Growth Over The Period 2012-2023
9.2 The Insulin Pump Market Will Continue to be the Largest Market Segment
9.3 Safety Concerns Will Continue to Restrain the Market
LIST OF TABLES
Table 2.1 Ideal Specification of an Infusion Pump
Table 2.2 Specifications of Syringe Pumps
Table 2.3 Advantages and Disadvantages of Syringe Infusion Pumps
Table 2.4 Advantages and Disadvantages of Infusion Pumps
Table 3.1 The Medical Device Market: Global Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Global Infusion Pumps Market: Revenues ($bn) and Market Shares (%) by Segment, 2011
Table 3.3 Infusion Pumps Market: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 3.4 European Infusion Pumps Market: Revenues ($bn), European Market Share (%) and Global Market Share (%) by Leading Countries, 2011
Table 3.5 The Global Infusion Pumps Market Forecast: Revenues ($bn, AGR%, CAGR %), 2011-2023
Table 3.6 Global Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR %), 2011-2017
Table 3.7 Global Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR %), 2017-2023
Table 3.8 Regional Infusion Pumps Market Forecast: CAGR (%), 2011-2017, 2017-2023 and 2011-2023
Table 3.9 US Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.10 European Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR%), 2011-2017
Table 3.11 European Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR%), 2017-2023
Table 3.12 The Japanese Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.13 The Chinese Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.14 The Indian Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.15 India Population Forecast by Age Group (%), 2010, 2015, 2020 and 2025
Table 3.16 Market Shares (%) of the Leading Regional Infusion Pumps Markets, 2011, 2017 and 2023
Table 4.1 Advantages and Disadvantages of Insulin Pumps
Table 4.2 Human Insulins and Analogues Leading Products: Sales ($bn) and Market Shares (%), 2011
Table 4.3 The Global Insulin Delivery Devices Market: Sales ($bn) and Market Shares (%), 2011
Table 4.4 Leading Products in the Insulin Pump Market, 2013
Table 4.5 The Insulin Pumps Market Forecast: Revenues ($bn, AGR %, CAGR %) 2011-2017
Table 4.6 The Insulin Pumps Market Forecast: Revenues ($bn, AGR %, CAGR %) 2017-2023
Table 4.7 Insulin Pumps Market: Drivers and Restraints, 2012-2023
Table 4.8 Development Pipeline for the Insulin Pump Market, 2013
Table 5.1 Types of Tubes Used in Enteral Feeding
Table 5.2 Leading Products in the Enteral Feeding Pumps Market, 2013
Table 5.3 The Global Enteral Feeding Pumps Market Forecast ($bn, AGR %, CAGR %), 2011-2023
Table 5.4 The Global Enteral Feeding Pumps Market Forecast ($bn, AGR %, CAGR %), 2017-2023
Table 5.5 The Drivers and Restraints for the Global Enteral Feeding Pumps Market, 2012-2023
Table 6.1 The Other Infusion Pumps Market Forecast ($bn, AGR %, CAGR %), 2011-2023
Table 6.2 Advantages and Disadvantages of Chemotherapy Pumps
Table 6.3 List of Leading Cancer Drugs: Revenue ($bn) and Market Shares (%), 2012
Table 6.4 Leading Cancer Drugs 2012: Key Facts
Table 6.5 Leading Products in the Chemotherapy Pump Market, 2012
Table 6.6 The Drivers and Restraints in the Global Chemotherapy Pump Market, 2012-2023
Table 6.7 Clinical Settings Where PCA Pumps are Used
Table 6.8 Advantages and Disadvantages of PCA Pumps
Table 6.9 The Global Narcotics Market Sales Forecast ($bn, AGR%, CAGR %), 2011-2022
Table 6.10 The Leading Products in the PCA Pump Market, 2012
Table 6.11 The Drivers and Restraints for the Global PCA Pump Market, 2012-2023
Table 6.12 R&D Pipeline for Narcotic Pain Drugs, 2013
Table 7.1 The Drug Delivery Market Sales ($bn) by Segment, 2011
Table 7.2 The Drug Delivery Technology Market Sales ($bn) by Country, 2011
Table 7.3 The Drug Delivery Technology Market Biannual Sales Forecast ($bn), 2011-2022
Table 7.4 Key Developments and Pipeline Products in the Drug Delivery Market, 2013
Table 8.1 SWOT Analysis of the Infusion Pumps Market, 2013
Table 8.2 Average Annual Costs Associated With Available Insulin Delivery Technologies
Table 8.3 The Infusion Pump and Related Product Recalls in the US, 2007-2013
Table 8.4 The Chinese and Indian Infusion Pump Market Forecast ($bn), 2011-2023
Table 9.1 The Global Infusion Pumps Market ($bn) in 2011, 2017 and 2023
Table 9.2 The Infusion Pumps Market ($bn) by Segment, 2011, 2017, and 2023
Table 2.1 Ideal Specification of an Infusion Pump
Table 2.2 Specifications of Syringe Pumps
Table 2.3 Advantages and Disadvantages of Syringe Infusion Pumps
Table 2.4 Advantages and Disadvantages of Infusion Pumps
Table 3.1 The Medical Device Market: Global Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Global Infusion Pumps Market: Revenues ($bn) and Market Shares (%) by Segment, 2011
Table 3.3 Infusion Pumps Market: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 3.4 European Infusion Pumps Market: Revenues ($bn), European Market Share (%) and Global Market Share (%) by Leading Countries, 2011
Table 3.5 The Global Infusion Pumps Market Forecast: Revenues ($bn, AGR%, CAGR %), 2011-2023
Table 3.6 Global Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR %), 2011-2017
Table 3.7 Global Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR %), 2017-2023
Table 3.8 Regional Infusion Pumps Market Forecast: CAGR (%), 2011-2017, 2017-2023 and 2011-2023
Table 3.9 US Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.10 European Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR%), 2011-2017
Table 3.11 European Infusion Pumps Market Forecast: Regional Revenues ($bn, AGR%, CAGR%), 2017-2023
Table 3.12 The Japanese Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.13 The Chinese Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.14 The Indian Infusion Pumps Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2023
Table 3.15 India Population Forecast by Age Group (%), 2010, 2015, 2020 and 2025
Table 3.16 Market Shares (%) of the Leading Regional Infusion Pumps Markets, 2011, 2017 and 2023
Table 4.1 Advantages and Disadvantages of Insulin Pumps
Table 4.2 Human Insulins and Analogues Leading Products: Sales ($bn) and Market Shares (%), 2011
Table 4.3 The Global Insulin Delivery Devices Market: Sales ($bn) and Market Shares (%), 2011
Table 4.4 Leading Products in the Insulin Pump Market, 2013
Table 4.5 The Insulin Pumps Market Forecast: Revenues ($bn, AGR %, CAGR %) 2011-2017
Table 4.6 The Insulin Pumps Market Forecast: Revenues ($bn, AGR %, CAGR %) 2017-2023
Table 4.7 Insulin Pumps Market: Drivers and Restraints, 2012-2023
Table 4.8 Development Pipeline for the Insulin Pump Market, 2013
Table 5.1 Types of Tubes Used in Enteral Feeding
Table 5.2 Leading Products in the Enteral Feeding Pumps Market, 2013
Table 5.3 The Global Enteral Feeding Pumps Market Forecast ($bn, AGR %, CAGR %), 2011-2023
Table 5.4 The Global Enteral Feeding Pumps Market Forecast ($bn, AGR %, CAGR %), 2017-2023
Table 5.5 The Drivers and Restraints for the Global Enteral Feeding Pumps Market, 2012-2023
Table 6.1 The Other Infusion Pumps Market Forecast ($bn, AGR %, CAGR %), 2011-2023
Table 6.2 Advantages and Disadvantages of Chemotherapy Pumps
Table 6.3 List of Leading Cancer Drugs: Revenue ($bn) and Market Shares (%), 2012
Table 6.4 Leading Cancer Drugs 2012: Key Facts
Table 6.5 Leading Products in the Chemotherapy Pump Market, 2012
Table 6.6 The Drivers and Restraints in the Global Chemotherapy Pump Market, 2012-2023
Table 6.7 Clinical Settings Where PCA Pumps are Used
Table 6.8 Advantages and Disadvantages of PCA Pumps
Table 6.9 The Global Narcotics Market Sales Forecast ($bn, AGR%, CAGR %), 2011-2022
Table 6.10 The Leading Products in the PCA Pump Market, 2012
Table 6.11 The Drivers and Restraints for the Global PCA Pump Market, 2012-2023
Table 6.12 R&D Pipeline for Narcotic Pain Drugs, 2013
Table 7.1 The Drug Delivery Market Sales ($bn) by Segment, 2011
Table 7.2 The Drug Delivery Technology Market Sales ($bn) by Country, 2011
Table 7.3 The Drug Delivery Technology Market Biannual Sales Forecast ($bn), 2011-2022
Table 7.4 Key Developments and Pipeline Products in the Drug Delivery Market, 2013
Table 8.1 SWOT Analysis of the Infusion Pumps Market, 2013
Table 8.2 Average Annual Costs Associated With Available Insulin Delivery Technologies
Table 8.3 The Infusion Pump and Related Product Recalls in the US, 2007-2013
Table 8.4 The Chinese and Indian Infusion Pump Market Forecast ($bn), 2011-2023
Table 9.1 The Global Infusion Pumps Market ($bn) in 2011, 2017 and 2023
Table 9.2 The Infusion Pumps Market ($bn) by Segment, 2011, 2017, and 2023
In 2011, the insulin infusion pumps market was valued at $2.0bn; this represents a total of 29.1% of the global infusion pumps market. In 2011, the market continued to recover from a series of set backs which included mass device recalls and a poor global economy, in the previous years. Our analyses show the insulin pumps market currently has a 24.1% share of the global insulin delivery devices market.
